pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-8066 |
Genomic Coordinates | chr4: 101240795 - 101240872 |
Description | Homo sapiens miR-8066 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-8066 | |||||||||||||||||||||||||||
Sequence | 48| CAAUGUGAUCUUUUGGAUGUA |68 | |||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | VMA21 | ||||||||||||||||||||
Synonyms | MEAX, XMEA | ||||||||||||||||||||
Description | VMA21, vacuolar ATPase assembly factor | ||||||||||||||||||||
Transcript | NM_001017980 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on VMA21 | |||||||||||||||||||||
3'UTR of VMA21 (miRNA target sites are highlighted) |
>VMA21|NM_001017980|3'UTR 1 AGTGAACATCACCTTTTTATAGCATTAAATTCATTTTTTAAAATGATAAATGCTGGAGGGGGCCATCTGATTTGAATAAA 81 GTTGAAAGAACATGTTAAAGTCAGTCTTAAGGAGTCACGTTTGAGTATGTAAATTTTGATCTTTCTAATATGTTGGTTTG 161 TATATTCAGTTTTAACTGTATGAATCTGATTTGCAAATGAGAATTTGGAAAAGTTAGTTACAAAGAAATATGTTAATTTA 241 ATTAGACAATACTCTGGAAGGAATTTTATCTTCTTTCAACAAAACATGTTTTATAGTATTCTGACTTACGGTTGCTTTTG 321 AGTTTTACTCATTTGGATATATTAAGATGCACACAGTGAAGCAAATTAAACTCCACTTTACGCTGGAATGCTTTCTTTAG 401 CATGAAAATACCAGGTCCTTGGATTTGGGATTTTAATTTCCTATGGAAAGTTGCTTAAATTGTGGACACTGGAATTAATC 481 TGAATGTCACTGAGGAATTTCACATGAAGTGTAATCCCTAGTCAATAAGAATTATCCATTACATTATTTTATGGGAAAAC 561 TAGGCTAAATTACATCCATTCAGGTAAAAGGACCTTAGCTTACTGAAGGATCTAAAGAGCAAAGCAAAGATCTCACTACT 641 CAAACACTCAGCCTGCTTCCTTCAAGTCCCCTTGCAGGCCAGCTTTGTGCTTTGCAGACCAACTTTTTAATGAGATACTT 721 TGCTTCCTCATTCAACATTGAAGCTAGGCTTCAATTAAAAGGTTCGAGGAAGCTCCATTTAAAATTGTTTTTTTTACTAT 801 TTTTTAAAATTGTAGTGTATATGATAGGAATTTGCATTTAAATATGTTCATTTTTGCATATGTTAGGAGTGGAAACAATC 881 TGGAAAACATTTTTTTTTCATCCAAAAAGTATTCTCCTTGGGCATATCTGATGGAAAAAAACCTTGATTTTATTTTCGTA 961 TCTTTAGTCTGTGTTCTTTCTAGTTATTTGGTACTAATTATGTGCAATCTAAAAACACTCCCACAAGTATTTGTTTTTTA 1041 ATTATAAAATCATAGTATATGTTCTTTGTAGAAAACTGGAAAAATACATATTCAAACAGGAAAAAAAATCAAAATTCCCC 1121 ATAATGTTGCCATCTAAAAATAACCTCTATTTTAGTTGATATCCCGTATTCATTTTTGAAAGCCATTCCTTAATGCTAGT 1201 TTGATACACACTAAAAGTTTAGCTTACAAGTTCAAATTCTGCCAGCTTTTCCTGACAGCTATTTGCATTTTTTTCAGATG 1281 AGTGATTATTGGCCATTTTCTTTTTCTTTTTCTTTATTTTATTTATTTATTTTTTTGAGACAGAGTTTTGCTCTGTTGCC 1361 CAGGCTGGAGTGCAGTGGTGCAATCTCGGCTCACTGCAACCTCTGCCTCCTGGGTTCAAGTGATTCTCCACCTCAGCCTC 1441 CCAAGTAGCTGGGACTACGGATGCCTGCCACCACGCCTGGCTAATTTTTTTTTGTATTTTTTTGTAGAGACGGGGTTTCA 1521 CCATGTTGTCCAGGCTAATCTTGAACTTGTGACCTCAGGTGATCCACCCGCCTCGGCCTCCGAAAGTGCTGGGATTACAG 1601 GCGTGAGCTACCACGCCCGGCCTTATTGACCATTTTCTAAATAAGCACATTCTATCTTTATTCTCTTAAAATTCAAATTT 1681 TCTGTTACTGATAATCCTAATACTAGGATTCTTGCTTAAGTATGTGAAACCATTACCGATTTGTTGTTCACATTTATTTT 1761 TTATGTTGTGAAACTGGACTAAAGGAATAGAGGGATGATTAGTCATAAAAGTCAAATAGCATTTGTGTTTAACTGTTGAG 1841 AAAAGTGAAAGATCAGTATGATTATTATGGAACTGTTTTTAATTCTTGCTTAAAGACTACAATTTTAGTATAATGACATT 1921 TGAGTCTAGGGTAGTATGTGGTAGATTTCTAGATGGTCCCTAATTAAGAAGTATTGTTGTATTTAGAATTGTCCACCTAA 2001 TTTCTTTTTATATAATGCCAAGGTATTTCTTGTGCTTTTGGGATCTTATGCTGTTTGTAAAATGTTACTGTCCAATGTTG 2081 GATTATTGTTTTGGTTTCAGGCATTTGCTGAATAGGTGATGATACATGGGTATTTTTCTGCAAGTATTTAAACCAGGGGC 2161 ATATGCAAAGGCAGTTGTAATTTCCTCTTGGAAAAAGCGCCAAATGTTTGAAGGTTAAAATCAAATGCTAGGGTTGATAT 2241 TTAGGCTTATAACAAAATAGGCTTGTTTTCAAAGCAGTTTTTTCCTAGAGTTTTAACTGTTAACTCACTAGTTTGCTGCT 2321 GTTTTTAACTATGTTAAATAACATATGGTATTTGGCAAATAGATTTATTTTTCAAAATGTCTCACTAGTTTCCTTTTACA 2401 CAATGTATATACTTCAAGATGTATAGAAAGGAAAGCTACAGTTGAGCCCTTATACATGTTTTAAGGTAGAAATATGTTCC 2481 CTATTGTTTGAAAACTGATTGTAAGAATAACCTCAGTTAGGAGATATAACTTGAAGTGTCAGTCCAAACTACTGATTTAA 2561 CCCTATTTACGGTAACACATTACCTTCCTCACCTCCTGTTTGGCCCTGGAGAATGTAGTCCTTTTTCTCATTTGTGTTGA 2641 GAAATGAAAAGTCTGCTGTAGAATGTATCTGATGTCATTAGTTCTTCAAATGGATACCATTGTACATATAACAGTAGAAT 2721 TTGGTTTGGGGTTGTTAGTGAAAAAAAATTTAAACCTGCCATTAAAAATCCCCATGTTTCATGGAAATCTAACAGAAATA 2801 CATTGTAATAATTAGAACATTTTGTTTTCTTTTTTCTTTTTTTTTTTTTCGAGACGGAGTTTTGCCCTTCTTGCCCAGGC 2881 TGGAGTGCAAGGGCGCAATCTCGGCTCGCTGCAACCTCCGCCTCCCGGGTTCAAGCAGTTCTCCTGCCTCAGCCCCCTGA 2961 GTACCTCAGATGACAGGTGCGTGCCACCACACCCGGCTAATTTTTGTATTTTTAGTAGAGACGGGGTTTCACCATGTTAG 3041 CCAGGCTAGTCTCGAACTCCTGACCTCAGGTGATCCACCCGCCTCCGCCTCCCAAAGTGCTGGGATTACAGGTATCAGCC 3121 ACCGTGCCTGGCCTAATAATTGGAACATTTTCATCATGAAAATGTCATCAGCTTTGCCAAAAGAAACAACCAATTGACTT 3201 GTTTGGCGTTTGTTTTCCATTTTCATGTCAATTTTATGTATACAGTTAGAATACCCAAGGAGACCACTAAAATCAGTTAA 3281 ACAAGTAGGGTATATACAAAGAAAGATGAAACCCGAAAGTACATAAAAAGGATTTAAATCCGATTTTAGATGTACCTAGT 3361 GTGTATTTCTTATCTCTAGACAAGTTCATGTTTATTGTTTAATTTATGCCCAAGTGAAGTTGTAAACTTATGGTTCAACT 3441 CTGACACAGAATTTGTCACTTGTCTGAGGTCAGTGGCAGGTTTCTCTGCTGTCAAGCACTCTGTGTCACCCACCAGATTA 3521 GTATAACTATTAATTCAGACTGTACTCCTATGTTTAAGATAATTTTTACAAGAGCTGGCTGAAGCAGCACATTAGTAACC 3601 TGACAAGATTTCTTTTTCCCTTTTCAGGGGGAAAGGGTCACCTTAAAAATAAATTATTTTCAGGGACTTTGGGAATCTAA 3681 TGATAAATATTACACATAATCTATGAATAGCTTAATCCTTTATATATTCCTTAAAATAGGAATTCCTCGACATCACTCCT 3761 GGCCACACTTTCCTTGCCTGTGTTGTTGCTATGTGTATTTGAAAGTAATATCTGCATTCCTTTTAAGATGTTCTGTAAGT 3841 CATATTTGTCAGTTATACAGAGTAGTCTTCCTTTTCCCCACGTTCAGTGTAATCTCACTGAACAGTAATAATAGCAATAG 3921 CTAACAACATCTGCACAGCACCTTACAGTTTGCAAAGAACGTTCACACATTCTCATTTGAGTTTTGCATAGTGAACCTGT 4001 TACGAGATGTCTCTTGACGTCGATGCTAAAAGTGTTAGAATCTTTACATCACTAGAGTCATTGAATATGCTGTAGTATTG 4081 AATAGTGCCCTGACTAGGGGGAGGATTTGGATGTGCTGCATTTCAAGCCGTGTATAATCATCAAAATGGGGGGCTTGAGT 4161 TCTTTAGCTACTTGAATCCGATTTACTTCTGTTAAGTGATGCTTTTCTAACCGTTTTCTGGATGGATTTTGTATTCACTA 4241 TATTGTAGCTTGTAATTTGTATAAATGTACCATCTGATGTCATTAAAAAAAGTGTTTGTAGTGCTAAAAAAAAAAAAAAA 4321 AAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000330374.6 | 3UTR | UAACACAUUACCUUCCUCACCUCCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
92 hsa-miR-8066 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060588 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT067440 | RIMKLB | ribosomal modification protein rimK like family member B | 2 | 2 | ||||||||
MIRT078862 | WBP2 | WW domain binding protein 2 | 2 | 2 | ||||||||
MIRT088062 | UBXN2A | UBX domain protein 2A | 2 | 4 | ||||||||
MIRT088214 | NUP50 | nucleoporin 50 | 2 | 2 | ||||||||
MIRT103494 | HOXA3 | homeobox A3 | 2 | 8 | ||||||||
MIRT135196 | TMBIM6 | transmembrane BAX inhibitor motif containing 6 | 2 | 4 | ||||||||
MIRT177727 | REEP3 | receptor accessory protein 3 | 2 | 2 | ||||||||
MIRT179439 | TBRG1 | transforming growth factor beta regulator 1 | 2 | 4 | ||||||||
MIRT191647 | SLC39A9 | solute carrier family 39 member 9 | 2 | 2 | ||||||||
MIRT192342 | KLF13 | Kruppel like factor 13 | 2 | 2 | ||||||||
MIRT212035 | RAPGEF2 | Rap guanine nucleotide exchange factor 2 | 2 | 2 | ||||||||
MIRT215387 | CREBRF | CREB3 regulatory factor | 2 | 2 | ||||||||
MIRT235001 | IER2 | immediate early response 2 | 2 | 2 | ||||||||
MIRT238793 | TPD52L1 | tumor protein D52 like 1 | 2 | 2 | ||||||||
MIRT273384 | SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 2 | 4 | ||||||||
MIRT280473 | UBR7 | ubiquitin protein ligase E3 component n-recognin 7 (putative) | 2 | 2 | ||||||||
MIRT298320 | SLC5A3 | solute carrier family 5 member 3 | 2 | 2 | ||||||||
MIRT309180 | SPATA5 | spermatogenesis associated 5 | 2 | 2 | ||||||||
MIRT354483 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT354710 | SLC25A36 | solute carrier family 25 member 36 | 2 | 2 | ||||||||
MIRT361004 | CDC5L | cell division cycle 5 like | 2 | 4 | ||||||||
MIRT366247 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 2 | ||||||||
MIRT405774 | EIF5 | eukaryotic translation initiation factor 5 | 2 | 2 | ||||||||
MIRT442640 | TBC1D12 | TBC1 domain family member 12 | 2 | 2 | ||||||||
MIRT443928 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT454287 | FXN | frataxin | 2 | 2 | ||||||||
MIRT454367 | ASAH2 | N-acylsphingosine amidohydrolase 2 | 2 | 2 | ||||||||
MIRT463574 | ZBTB39 | zinc finger and BTB domain containing 39 | 2 | 6 | ||||||||
MIRT464484 | UGCG | UDP-glucose ceramide glucosyltransferase | 2 | 2 | ||||||||
MIRT466866 | STX6 | syntaxin 6 | 2 | 2 | ||||||||
MIRT467283 | SPNS1 | sphingolipid transporter 1 (putative) | 2 | 2 | ||||||||
MIRT470298 | PPTC7 | PTC7 protein phosphatase homolog | 2 | 2 | ||||||||
MIRT471630 | PAPD7 | poly(A) RNA polymerase D7, non-canonical | 2 | 2 | ||||||||
MIRT472802 | MTMR4 | myotubularin related protein 4 | 2 | 4 | ||||||||
MIRT474708 | KIF3A | kinesin family member 3A | 2 | 2 | ||||||||
MIRT478256 | DDX3X | DEAD-box helicase 3, X-linked | 2 | 2 | ||||||||
MIRT479330 | CERS2 | ceramide synthase 2 | 2 | 2 | ||||||||
MIRT480658 | BSCL2 | BSCL2, seipin lipid droplet biogenesis associated | 2 | 2 | ||||||||
MIRT481954 | ANKRD11 | ankyrin repeat domain 11 | 2 | 2 | ||||||||
MIRT482895 | IAH1 | isoamyl acetate-hydrolyzing esterase 1 homolog | 2 | 4 | ||||||||
MIRT493634 | HIC2 | HIC ZBTB transcriptional repressor 2 | 2 | 2 | ||||||||
MIRT500847 | SYPL1 | synaptophysin like 1 | 2 | 4 | ||||||||
MIRT502035 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | 2 | 2 | ||||||||
MIRT502185 | IGSF3 | immunoglobulin superfamily member 3 | 2 | 4 | ||||||||
MIRT502605 | DNAJB9 | DnaJ heat shock protein family (Hsp40) member B9 | 2 | 10 | ||||||||
MIRT502977 | CCNL1 | cyclin L1 | 2 | 8 | ||||||||
MIRT504725 | PLEKHA6 | pleckstrin homology domain containing A6 | 2 | 10 | ||||||||
MIRT504778 | CLEC2D | C-type lectin domain family 2 member D | 2 | 4 | ||||||||
MIRT505786 | SATB1 | SATB homeobox 1 | 2 | 4 | ||||||||
MIRT510090 | PPWD1 | peptidylprolyl isomerase domain and WD repeat containing 1 | 2 | 4 | ||||||||
MIRT520010 | YY1 | YY1 transcription factor | 2 | 4 | ||||||||
MIRT532552 | TXNL1 | thioredoxin like 1 | 2 | 2 | ||||||||
MIRT533433 | TRPS1 | transcriptional repressor GATA binding 1 | 2 | 2 | ||||||||
MIRT537459 | FAM84B | family with sequence similarity 84 member B | 2 | 2 | ||||||||
MIRT541825 | SV2B | synaptic vesicle glycoprotein 2B | 2 | 2 | ||||||||
MIRT543222 | TMEM117 | transmembrane protein 117 | 2 | 2 | ||||||||
MIRT551088 | DDX52 | DExD-box helicase 52 | 2 | 2 | ||||||||
MIRT551500 | UGT2B4 | UDP glucuronosyltransferase family 2 member B4 | 2 | 2 | ||||||||
MIRT552326 | ZNF791 | zinc finger protein 791 | 2 | 2 | ||||||||
MIRT553213 | TXLNG | taxilin gamma | 2 | 2 | ||||||||
MIRT554590 | RRAGC | Ras related GTP binding C | 2 | 2 | ||||||||
MIRT559004 | CA8 | carbonic anhydrase 8 | 2 | 2 | ||||||||
MIRT559134 | BTG3 | BTG anti-proliferation factor 3 | 2 | 4 | ||||||||
MIRT559409 | GDNF | glial cell derived neurotrophic factor | 2 | 4 | ||||||||
MIRT560678 | SRFBP1 | serum response factor binding protein 1 | 2 | 2 | ||||||||
MIRT560954 | POTED | POTE ankyrin domain family member D | 2 | 2 | ||||||||
MIRT562856 | C17orf58 | chromosome 17 open reading frame 58 | 2 | 2 | ||||||||
MIRT563003 | MOCS2 | molybdenum cofactor synthesis 2 | 2 | 2 | ||||||||
MIRT564545 | CCDC80 | coiled-coil domain containing 80 | 2 | 2 | ||||||||
MIRT566272 | PTAR1 | protein prenyltransferase alpha subunit repeat containing 1 | 2 | 2 | ||||||||
MIRT566510 | PAWR | pro-apoptotic WT1 regulator | 2 | 2 | ||||||||
MIRT572103 | EFNB2 | ephrin B2 | 2 | 2 | ||||||||
MIRT574576 | NLGN4X | neuroligin 4, X-linked | 2 | 4 | ||||||||
MIRT576574 | Serpine1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 | 2 | 2 | ||||||||
MIRT610815 | POT1 | protection of telomeres 1 | 2 | 2 | ||||||||
MIRT624589 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT627567 | SMAD6 | SMAD family member 6 | 2 | 2 | ||||||||
MIRT632675 | MTX3 | metaxin 3 | 2 | 2 | ||||||||
MIRT689265 | WDR83OS | WD repeat domain 83 opposite strand | 2 | 2 | ||||||||
MIRT694310 | COPB2 | coatomer protein complex subunit beta 2 | 2 | 2 | ||||||||
MIRT697721 | USP8 | ubiquitin specific peptidase 8 | 2 | 2 | ||||||||
MIRT700209 | RFWD3 | ring finger and WD repeat domain 3 | 2 | 2 | ||||||||
MIRT704399 | CTSS | cathepsin S | 2 | 2 | ||||||||
MIRT710665 | CSTF2T | cleavage stimulation factor subunit 2 tau variant | 2 | 2 | ||||||||
MIRT711953 | SLC7A14 | solute carrier family 7 member 14 | 2 | 2 | ||||||||
MIRT712596 | ADCYAP1 | adenylate cyclase activating polypeptide 1 | 2 | 2 | ||||||||
MIRT712692 | TNFAIP2 | TNF alpha induced protein 2 | 2 | 2 | ||||||||
MIRT714171 | PPP1R2 | protein phosphatase 1 regulatory inhibitor subunit 2 | 2 | 2 | ||||||||
MIRT715964 | CES4A | carboxylesterase 4A | 2 | 2 | ||||||||
MIRT722781 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT724505 | MSMO1 | methylsterol monooxygenase 1 | 2 | 2 |